ARA-290-10mg

ARA‑290 (also known as Cibinetide) is a synthetic peptide derived from the erythropoietin (EPO) helix‑B domain, supplied as a high‑purity lyophilised powder for controlled laboratory research. It is widely used in scientific environments investigating innate repair receptor (IRR) signalling, inflammatory pathways, and peptide‑mediated cellular response modulation.

Its structure allows researchers to explore non‑erythropoietic EPO‑derived signalling, making ARA‑290 a valuable tool for studies focused on cellular protection, inflammation models, and peptide‑receptor interactions.

Areas of Research Interest
Innate Repair Receptor (IRR) Pathway Studies
Used in research exploring how EPO‑derived peptides interact with IRR and influence downstream cellular signalling.

Inflammation & Cytokine Modulation Models
Included in controlled laboratory environments studying peptide‑mediated modulation of inflammatory cascades.

Cellular Stress Response Research
Investigated in models examining how synthetic peptides influence cellular resilience under stress conditions.

Peptide Structure–Function Analysis
Used in studies evaluating stability, receptor affinity, and sequence‑specific behaviour of helix‑B–derived peptides.

Technical Information
Chemical Name: Cibinetide (ARA‑290)

Molecular Formula: C₁₄₉H₂₅₄N₄₄O₄₁

Molecular Weight: 3381.8 g/mol

Sequence: ALA‑PRO‑GLU‑GLU‑LEU‑GLU‑ARG‑ALA‑LEU‑GLU‑LYS‑GLY‑ALA‑GLY‑PRO‑GLY‑GLY‑GLY

Classification: Helix‑B EPO‑derived synthetic peptide

Storage Guidelines
Store lyophilised peptide at –20°C or below for long‑term stability.

Short‑term storage at room temperature is acceptable.

After reconstitution, keep at 2–8°C.

Protect from light and moisture.

Solubility
Soluble in sterile water and common aqueous laboratory buffers.

Compliance Notice
For laboratory research use only. Not for human or animal administration.